Inquisatex is a drug discovery company dedicated to delivering a novel, safe, and effective epigenetic therapy for sickle cell disease to those in need. Inquisatex is forging new paths to drug discovery without costly overhead by:

Utilizing academic partnerships to reduce costs

Collaborating with key leaders in Epigenetics

Using State-of-the-art informatics and computational data